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Abstract
Among heterocyclic compounds, quinoline is a privileged scaffold that appears 
as an important construction motif for the development of new drugs. Quinoline 
nucleus is endowed with a variety of therapeutic activities, and new quinolone 
derivatives are known to be biologically active compounds possessing several 
pharmacological activities. Many new therapeutic agents have been developed 
by using quinoline nucleus. Hence, quinoline and its derivatives form an impor-
tant class of heterocyclic compounds for the new drug development. Numerous 
synthetic routes have been developed for the synthesis of quinoline and its deriva-
tives due to its wide range of biological and pharmacological activities. The article 
covers the synthesis as well as biological activities of quinoline derivatives such as 
antimalarial, anticancer, antibacterial, anthelmintic, antiviral, antifungal, anti-
inflammatory, analgesic, cardiovascular, central nervous system, hypoglycemic, 
and miscellaneous activities.
Keywords: quinoline, heterocyclic compound, quinoline derivatives, synthesis, 
biological activity
1. Introduction
Quinoline 1 or 1-azanaphthalene or benzo[b]pyridine is an aromatic nitrogen-
containing heterocyclic compound having a molecular formula of C9H7N, and the 
molecular weight is 129.16. Being a weak tertiary base, it forms salts with acids and 
exhibits reactions similar to benzene and pyridine. It participates in both electro-
philic and nucleophilic substitution reactions.
Quinoline moiety commonly exists in various natural compounds (Cinchona 
alkaloids), and pharmacological studies have shown that the quinolone ring 
system is present in many compounds exhibiting a broad range of biological 
activities. Quinoline has been found to have antibacterial, antifungal, antimalar-
ial, anthelmintic, anticonvulsant, cardiotonic, anti-inflammatory, and analgesic 
activities.
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2. Synthesis
In the literature, a number of established protocols have been reported for the 
synthesis of quinoline ring, which can be altered to produce a number of differently 
substituted quinolines. The quinoline ring has been generally synthesized by vari-
ous conventional named reactions such as Skraup, Doebner-Von Miller, Pfitzinger, 
Friedlander, Conrad-Limpach, and Combes synthesis (Figure 1) [1].
Apart from the conventional methods, a vast number of synthetic routes have 
been developed for the synthesis of quinoline and quinoline derivatives. Chen et al. 
reported the synthesis of 2,4-disubstituted quinolines, 2 by the condensation of 
2-iodoanilines with alkynyl aryl ketones using nickel catalyst [2].
2,4-Disubstituted quinolones, 3 have been obtained by the cyclization of 
2-aminoaryl ketones with phenylacetylenes. This reaction takes place in ionic liquid 
medium ([hmim]PF6) in the presence of zinc trifluoromethanesulfonate catalyst 
[3]. Lekhok et al. synthesized the same product in the presence of catalytic amount 
of indium(III) trifluoromethanesulfonate (In(CF3SO3)3) under microwave and 
solvent-free conditions [4].
Figure 1. 
Conventional methods of synthesis of various substituted quinolines.
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2,4-Diphenyl-2-methyl-1,2-dihydroquinoline, 4 has been prepared by the 
condensation followed by cyclization of aniline and acetophenone. The reaction 
proceeds with the help of a zeolite catalyst, E4a [5].
2,3,4-Trisubstituted quinolones, 5 have been synthesized by Friedlander annula-
tion of 2-amino substituted aromatic ketones and reactive methylene group con-
taining carbonyl compounds in the presence of ethyl ammonium nitrate (EAN) [6].
By stirring 2-aminoaryl ketones and various α-methylene ketones in the pres-
ence of dodecylphosphonic acid (DPA) catalyst in water or solvent-free conditions, 
poly-substituted quinolones, 6 have been synthesized [7].
2-Aminobenzyl alcohol reacts with ketones or alcohols in the presence of a base, 
and benzophenone resulted in the formation of poly-substituted quinolones, 7 [8]. 
Here, benzophenone acts as a hydride scavenger.
Horn et al. reported the synthesis of quinolines, 8 from α, β-unsaturated ketones 
and o-aminophenylboronic acid derivatives [9]. This method is the modification of 
the conventional Skraup-Doebner-Von Miller synthesis and that the reaction 
proceeded under basic conditions.
3,4-Dihydroquinolin-2-ones, 9 have been synthesized by treating 2-iodoanilines 
and various acrylates using azobisisobutyronitrile (AIBN) in the presence of 
tributyltin hydride [10].
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Wang et al. developed a method for the synthesis of 2-phenylquinoline-4-car-
boxylic acids, 10 by the treatment of pyruvic acid with substituted aniline and 
benzaldehyde in the presence of rare-earth metal catalysts in water under reflux 
condition [11].
Kouznetsov et al. synthesized phenyl-substituted quinolones, 11 by reacting 
ethyl vinyl ether or ethyl vinyl sulfide with N-arylaldimine in the presence of Lewis 
acidic catalysts such as boron trifluoride etherate (BF3.OEt2) to obtain 2,4-substi-
tuted tetrahydroquinolines. The tetrahydroquinolines were aromatized to 2-phenyl-
substituted quinolines under vacuum distillation in the presence of p-TSOH [12].
Wang et al. reported the synthesis of 2-phenyl-4-alkoxy quinolines, 12 by 
cyclocondensation of 2-(2-trimethylsilyl)ethynyl) aniline with aromatic aldehydes 
in the presence of sulfuric acid as catalyst in methanol solvent [13].
Two molecules of o-haloacetophenones condensed with urea or primary amines 
yielded certain halogen-substituted quinolones, 13. The halogen-substituted 
quinolines were formed through the cleavage of C(sp2)–halogen and α-C(sp3)–H 
bonds and the formation of new bonds in a selective manner [14].
A one-pot reaction of 2-aminoaryl ketones with certain arylacetylenes results in 
the formation of 2,4-disubstituted quinolones, 14. The reaction was performed in a 
green synthetic route using potassium dodecatugstocobaltate trihydrate 
(K5CoW12O40.3H2O) as a recyclable and eco-friendly catalyst under microwave and 
solvent-free conditions [15].
5Quinoline Heterocycles: Synthesis and Bioactivity
DOI: http://dx.doi.org/10.5772/intechopen.81239
Kowsari et al. synthesized certain quinolones, 15 by reacting isatin with aryl 
methyl ketones in the presence of basic ionic liquids in water [16]. The reaction was 
conducted under ultrasound green synthetic conditions. The main advantages of 
this procedure are (i) a green method, (ii) milder and shorter reaction time, and 
(iii) higher yields and selectivity without a transition metal catalyst.
1,4-Diazabicyclo[2.2.2]octane (DABCO) promoted structurally diverse 
2- alkoxy- and 2-aryloxy-3-substituted quinolones, 16 that have been synthesized by 
treating o-alkynylaryl isocyanides with alcohols and phenols [17]. DABCO initiates 
the reaction as a nucleophile and facilitates the formation of the product as a leaving 
group being replaced by oxygen nucleophiles.
Benzimidoyl chlorides when treated with 1-(1-(allyloxy)prop-2-ynyl)benzene 
(1,6-enynes) yielded diverse quinoline derivatives, 17 via a domino palladium-
catalyzed Sonogashira coupling and followed by cyclization [18].
Diversified quinolones, 18 have been synthesized by the intramolecular cyclocon-
densation of 1-azido-2-(2-propynyl)benzenes using electrophilic reagents (I2, Br2, 
ICl, NBS, NIS, and HNTf2) in nitromethane at 0°C to room temperature. The reaction 
also proceeds in the presence of AuCl3/AgNTf2 catalysts in THF at 100°C [19].
3. Biological activity
3.1 Antimalarial
Quinolines are known for their excellent antimalarial properties. Raynes et al. 
developed bisquinolines, 19, 20 that exhibit antimalarial activity against chloro-
quine-resistant and chloroquine-sensitive parasites [20]. Derivatives of ferrochloro-
quine, 21 were also found to possess antimalarial activity [21]. In these derivatives, 
the carbon skeleton of chloroquine is replaced by ferrocene group. Modapa et al. 
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reported that the synthesis of ureido-4-quinolinamides, 22 showed antimalarial 
activity at MIC 0.25 mg/mL against chloroquine-sensitive Plasmodium falciparum 
strain [22]. Several 7-chloroquinolinyl thioureas, 23, 24 have been synthesized by 
Mahajan et al. that possess excellent antimalarial properties [23]. Kovi et al. synthe-
sized a chloroquinolyl derivative, 25 that has an excellent antimalarial activity even 
at very low concentrations [24]. Acharya et al. reported the synthesis and potent 
antimalarial activity of certain pyridine-quinoline hybrid conjugates, 26, 27 against 
chloroquine susceptible P. falciparum strain [25]. Shiraki et al. produced some 
5-aryl-8-aminoquinolines, 28 with good antimalarial activity and had mild hemo-
lytic activity than tafenoquine [26]. Singh et al. developed several antimalarial 
4-anilinoquinolines, 29 which showed good antimalarial activity against chloro-
quine-sensitive P. falciparum strains [27]. Novel hybrid conjugates of N-(7-
chloroquinolin-4-yl) piperazine-1-carbothioamide and 1,3,5-triazine derivatives, 
30 have been synthesized by Bhat et al. These hybrid conjugates possess consider-
able antimalarial activity against both wild and mutant parasites on changing the 
pattern of substitution [28]. McNulty et al. developed 4-arylquinoline-2-carboxyl-
ate derivatives, 31 which show antiprotozoal activity against the pathogenic parasite 
Toxoplasma gondii [29].
3.2 Anti-inflammatory activity
A quinoline derivative, 32 with strong anti-inflammatory activity was syn-
thesized by Baba et al. in adjuvant arthritis rat model [30]. Chen et al. developed 
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2-(furan-2-yl)-4-phenoxy-quinoline derivatives, 33, 34 that inhibit the lysozyme 
and β-glucuronidase release [2]. Few quinoline derivatives, 35, 36 have been 
synthesized and evaluated by Gilbert et al. for treating osteoarthritis and that are 
amino-acetamide inhibitors of aggrecanase-2 [31].
3.3 Analgesic activity
4-Substituted-7-trifluoromethylquinolines 37, 38 have been developed by Abadi 
et al., and these derivatives were found to possess excellent analgesic activity with 
nitric oxide releasing characteristics [32]. Gomtsyan et al. synthesized an analgesic 
active derivative, 39. The activity is due to its antagonism at vanilloid receptors [33]. 
Some quinoline derivatives, 40 were synthesized by Manera et al. that show 
analgesic activity and are selective agonists at cannabinoid CB2 receptors [34].
3.4 Antibacterial
Ma et al. reported the synthesis and antibacterial evaluation of phenoxy-, 
phenylthio-, and benzyloxy-substituted quinolones, 41 [35]. A few 8-substituted 
quinoline carboxylic acids, 42 were synthesized by Sanchez et al. that showed 
antibacterial activity [36]. Upadhayaya et al. developed 3-benzyl-6-bromo-2-me-
thoxy quinoline derivatives, 43, and these derivatives are active against 
Mycobacterium tuberculosis H37Rv strain [37]. A few analogues of 7-chloro quino-
lones, 44 were synthesized by De Souza et al., and these derivatives were found to 
be effective against multidrug-resistant tuberculosis [38]. Lilienkampf et al. 
synthesized quinoline-based compounds containing an isoxazole unit and side 
chain, 45 that was active against Mycobacterium tuberculosis [39]. The novel hybrid 
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conjugates of N-(7-chloroquinolin-4-yl) piperazine-1-carbothioamide and 1,3,5-tri-
azine derivatives, 30 synthesized by Bhat et al. also showed excellent antibacterial 
activity against several Gram-positive and Gram-negative microorganisms [40].
3.5 Antitumor
Some amido-anilinoquinolines, 46 were synthesized by Scott et al. that act as 
antitumor agents by inhibiting CSF-1R kinase [41]. Certain derivatives of 
4-hydroxyquinolines, 47 were synthesized by Mai et al. that showed histone 
acetyltransferase (HAT) inhibitory activity [42]. A few 3-cyanoquinolines, 48 were 
developed by Miller et al. as inhibitors of growth factor receptors (IGF-1R) for 
treating cancer [43]. 4-Anilinoquinolines, 49 were synthesized by Assefa et al. 
which were found to contain tyrosine kinase inhibitors [44]. Quinoline carboxylic 
acids, 50 have been synthesized by Chen et al. that act as antitumor compounds by 
inhibiting insulin-like growth factors [45]. A few c-Met kinase inhibitory quino-
lones, 51 were developed by Wang et al. with IC50 < 1 nM. These derivatives were 
found to show the inhibition of c-Met phosphorylation in c-Met-dependent cell 
lines [46]. Marganakop et al. developed few 6,7,8-substituted thiosemicarbazones 
of 2-chloro-3-formyl-quinoline derivatives, 52 which exhibit excellent anticancer 
activities [47]. Recently, some quinoline derivatives, 53 were synthesized as novel 
Raf kinase inhibitors with potent and selective antitumor activities. These deriva-
tives were synthesized by modifying the structure of sorafenib [48].
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3.6 Antifungal
Certain tetrahydroquinolines, 54 were synthesized by Gholap et al. which were 
found to possess good antifungal activity against Candida albicans, Fusarium oxys-
porum, and Mucor fungi [49]. Kharkar et al. synthesized few quinoline derivatives, 
55 that show good antifungal properties [50]. Kumar et al. developed few non-azole 
antimycotic agents having secondary amine attached 2-chloroquinolines, 56 and 
evaluated their antifungal activity against Penicillium citrinum, Aspergillus niger, 
Monascus purpureus, and A. flavus sp. [51].
3.7 Antiviral
Several mono- and poly-substituted quinolones, 57–59 synthesized by Fakhfakh 
et al. were found to exhibit activity against HIV-1 [52]. Ghosh et al. synthesized 
anilidoquinoline derivatives, 60 which were found to possess an excellent antiviral 
activity against Japanese encephalitis virus [53]. A few quinoline derivatives, 61 
possessing the behavior as HIV-1 Tat-TAR interaction inhibitors were synthesized 
by Chen et al. [45]. Massari et al. synthesized few desfluoroquinolones, 62 for 
treating HIV infection [54].
3.8 Anthelmintic
Substituted 2,4-arylquinolines, 63–66 have been synthesized by Rossiter et al. 
which possess good anthelmintic activity against levamisole-, ivermectin-, and 
thiabendazole-resistant strains of H. contortus [55].
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3.9 Antiprotozoal
2-Propyl quinoline and 2-(3-methyloxiran-2-yl)quinoline alkaloids 67, 68 
isolated from G. longiflora plant were found to show antileishmanial activity 
against Leishmania spp. [56]. Alkenyl and alkynyl quinolones, 69, 70 reported by 
Fakhfakh et al. were found to have antiprotozoal activity against cutaneous 
leishmaniasis, African trypanosomiasis, Chagas disease, and visceral leishmaniasis 
[52]. Ma et al. developed a few quinolones, 71 that showed activity against 
Trypanosoma cruzi [35].
3.10 Cardiovascular activity
Srimal et al. demonstrated the hypotensive activity of centhaquin, 72, and it was 
found to show the property of reducing the blood pressure in cat in a dose-depen-
dent manner [57]. Quinoline-4-carboxylic acids, 73 have been synthesized by Lloyd 
et al. that are angiotensin II receptor antagonists and thereby act as hypotensive 
agents [58]. Certain biarylether amide quinolones, 74 have been developed by 
Bernotas et al. which act as liver X receptor agonists and are useful in the situation 
of dyslipidemia [59]. Phenyl acetic acid-based quinolones, 75 have been developed 
by Hu et al. which act as agonists at liver X receptors and found to have good 
binding affinity for LXRb and LXRa receptors [60]. A few 4-thiophenyl quinolones, 
76 have been developed by Cai et al. that are HMG-CoA reductase inhibitors and 
useful as hypocholesterolemic agents [61]. Tetrahydroquinolines, 77 which inhibit 
the cholesteryl ester transfer protein have been synthesized by Rano et al. [62]. 
Certain tetrahydroquinolinamines, 78 have been developed by Ramos et al. which 
are found to inhibit platelet aggregation [63].
11
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3.11 Reproductive system
Tetrahydroquinolines, 79 have been synthesized by Wallace et al. that are selec-
tive estrogen receptor modulators [64]. Bi et al. developed few quinolones, 80 which 
are potent PDE5 inhibitors thus are useful in the treating erectile dysfunction [65].
3.12 Miscellaneous
Quinolines and quinoline derivatives possess a number of miscellaneous biologi-
cal activities also. Evans et al. synthesized few quinolones, 81 that are leukotriene 
synthesis inhibitors [66]. 1,2,3,4-Tetrahydroquinoline-2,2,4-trione oximes, 82 are 
developed by Cai et al. that act as antagonists of NDMA in glycine receptors and 
also found to be used as agents against neurodegenerative diseases (e.g., Alzheimer’s 
disease) [61]. Lunniss et al. developed few selective PDE4 inhibitor quinolones 83, 
84 which are useful in chronic obstructive pulmonary disorder [67]. Bachiller et al. 
have developed few tacrine–8-hydroxyquinoline hybrids, 85 that show activity 
against Alzheimer’s [68]. Tetrahydroquinoline-6-yloxy propanes, 86 have been 
developed by Shakya et al. which show the β-3 agonists [69]. Few aminoalkoxy-
quinolines, 87 which act as somatostatin receptor subtype-2 agonists have been 
developed by Wolkenberg et al. which are useful in proliferative diabetic retinopa-
thy and also found utility in exudative age-related macular degeneration [70].
4. Conclusion
Since quinoline and its derivatives are known for their wide spectrum of phar-
macological activities, a number of synthetic methods have been developed from 
time to time for their synthesis by conventional, homogeneous, and heterogeneous 
acid-catalyzed methods; rare-earth-catalyzed, transition metal-catalyzed, radical-
catalyzed, microwave-assisted, ultrasound-promoted, or solvent-free conditions, 
and many more. This book chapter will be very useful to the researcher working in 
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this field, and it would help them to develop new synthetic methods for the potent 
quinoline derivatives with good or enhanced biological activities for the future.
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